Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing (CD91)

Xetra
Currency in EUR
34.45
+0.35(+1.03%)
Delayed Data·
Day's Range
34.1734.59
52 wk Range
24.0037.51

Key Statistics

Morning Star Rating
Risk Rating
Bid / Ask
35.18 / 35.27
Prev. Close
34.45
Price Open
35.22
Volume
1,781
Average Vol. (3m)
17,178
1-Year Change
45.48%
Day’s Range
35.18-35.22
52-Week Range
24.00-37.51
Market Cap
12.26B
Expense Ratio
0.65%
How do you feel today about CD91?
Vote to see community's results!
or

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Performance

Name
YTD
3M
1Y
3Y
5Y
10Y
Growth of 10001,4491,2771,4331,5991,5122,454
Fund Return+44.86%+27.71%+43.29%+16.93%+8.63%+9.39%
Rank in Category22923321018815492
Percentile Rank706858586563
Upside
NEM15.86%
aa.aa
58.26+2.64%1,252,922
AEM14.99%
aa.aa
118.93+2.42%573,815
WPM10.06%
aa.aa
89.80+2.83%516,669
SKE2.29%
aa.aa
21.660+4.29%695,024
ARIS2.23%
aa.aa
9.17+1.78%1,485,031
SAND2.18%
aa.aa
9.400+4.10%1,084,482
SSRM2.18%
aa.aa
12.74+3.49%805,403
B2.18%
aa.aa
20.82+1.76%478,180
PPTA2.17%
aa.aa
16.54+1.78%762,869
NGD2.16%
aa.aa
4.9500+4.21%2,051,018

Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing Company Profile

Lyxor NYSE Arca Gold BUGS (DR) UCITS ETF is an exchange traded fund launched by Lyxor Funds Solutions S.A. It is managed by Commerzbank AG. The fund invests in the public equity markets of the United States. It uses derivatives such as swaps to invest in the stocks of companies operating in the gold mining sector. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the NYSE Arca Gold BUGS Index (Price), by employing synthetic replication methodology. It was formerly known as ComStage ETF - NYSE Arca Gold BUGS UCITS ETF. The fund was formerly known as ComStage - NYSE Arca Gold BUGS UCITS ETF. Lyxor NYSE Arca Gold BUGS (DR) UCITS ETF was formed on May 11, 2010 and is domiciled in Luxembourg.

Industry
-
Sector
-
0
Equity Type
ETF
Market
Germany

FAQ

How is the performance of CD91?

As of 01 Jul 2025, CD91 is trading at a price of 34.45, with a previous close of 34.45. The stock has fluctuated within a day range of 34.17 to 34.59, while its 52-week range spans from 24.00 to 37.51.

What is the current price of CD91?

The CD91 stock price today is 34.45.

Does CD91 Pay Dividends? What’s The Current Dividend Yield?

The Amundi NYSE Arca Gold BUGS UCITS USD Distributing dividend yield is 2.37%.

What is the P/E ratio of CD91?

The P/E ratio for CD91 is 13.74.

From a Technical Analysis Perspective, Is CD91 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.